Q2 2021 Holdings
Filed 2021-08-16 | 12 holdings | $41.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $20.5M | 336,817 | 49.1% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $16.3M | 126,985 | 39.1% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $4.4M | 250,000 | 10.5% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $301.1K | 1,859,926 | 0.7% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $220.9K | 1,760,346 | 0.5% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $29.2K | 335,918 | 0.1% |
| Verve Therapeutics Inc | COM | 92539P101 | $6.2K | 103,013 | 0.0% |
| Inhibrx Inc(INBXUSD) | COM | 45720L107 | $6.2K | 225,480 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $6.0K | 208,524 | 0.0% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $4.4K | 104,186 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $4.4K | 119,775 | 0.0% |
| Generation BIO Co(GBIOGBX) | COM | 37148K100 | $289 | 10,738 | 0.0% |